KEY-OBS Preclinical Contract Research Organization is a leading CRO based in France, specializing in preclinical pharmacology and behavioral neuroscience research focused on central nervous system (CNS) disorders.
Our expert teams support pharmaceutical and biotech partners in developing innovative treatments for brain-related diseases such as Alzheimer’s disease, autism spectrum disorders, ADHD, anxiety, and depression. With a scientific and client-centered approach, KEY-OBS delivers high-quality data in compliance with regulatory standards.
Our capabilities span from early-stage preclinical discovery to advanced pharmacology, using robust behavioral, biochemical, and imaging endpoints. As a CNS-specialized CRO, we are recognized for our agility, scientific rigor, and custom-tailored study designs that align with client goals and timelines.
If you are looking for a reliable and experienced preclinical partner in CNS research, visit our website and reach out to our scientific team to discuss your project: www.key-obs.com